| Literature DB >> 34084784 |
Thomas R Skinner1, Joseph Churton1, Timothy P Edwards1, Farzad Bashirzadeh1, Christopher Zappala1, Justin T Hundloe1, Hau Tan2, Andrew J Pattison1, Maryann Todman1, Gunter F Hartel3, David I Fielding1.
Abstract
BACKGROUND: The difference in patient comfort with conscious sedation versus general anaesthesia for bronchoscopy has not been adequately assessed in a randomised trial. This study aimed to assess if patient comfort during bronchoscopy with conscious sedation is noninferior to general anaesthesia.Entities:
Year: 2021 PMID: 34084784 PMCID: PMC8165373 DOI: 10.1183/23120541.00895-2020
Source DB: PubMed Journal: ERJ Open Res ISSN: 2312-0541
FIGURE 1Consolidated Standards of Reporting Trials diagram of participant enrolment, allocation, follow-up and analysis.
Subject characteristics
| 49 | 44 | ||
| Age years | 58.2±13.7 | 61.3±14.0 | 0.28 |
| Female | 19 (38.8) | 12 (27.3) | 0.34 |
| Charlson comorbidity index | 0.86 | ||
| 0–1 (low) | 23 (46.9) | 19 (43.2) | |
| 2–3 (moderate) | 11 (22.4) | 11 (25.0) | |
| ≥4 (high) | 12 (24.5) | 14 (31.8) | |
| Emotional state score | |||
| Pre-procedure | 4.6±3.4 | 4.7±3.9 | 0.91 |
| Post-procedure | 2.4±1.5 | 2.5±1.6 | 0.79 |
| Procedure | 0.23 | ||
| Standard bronchoscopy (not for investigation of malignancy) | 6 | 2 | |
| Standard bronchoscopy (for investigation of malignancy) | 8 | 4 | |
| TBLB | 6 | 4 | |
| Convex EBUS TBNA | 12 | 13 | |
| Radial EBUS guide sheath biopsy | 13 | 15 | |
| Combined: TBLB/EBUS TBNA | 1 | 1 | |
| Combined: EBUS TBNA/EBUS guide sheath | 1 | ||
| Therapeutic bronchoscopy | 2 | 5 | |
| 47 | 39 | ||
| Final diagnosis: malignant | 13 (27.7) | 18 (46.2) | 0.11 |
| Nonsmall cell lung cancer | 13 | 13 | |
| Small cell lung cancer | 0 | 0 | |
| Lymphoma | 0 | 2 | |
| Metastatic malignancy | 0 | 3 | |
| Final diagnosis: nonmalignant | 34 (72.3) | 21 (53.8) | |
| Sarcoidosis | 1 | 2 | |
| Infective/inflammatory | 19 | 14 | |
| Benign/no abnormality detected | 10 | 4 | |
| Other | 4 | 1 | |
| 14 | 14 | ||
| Final diagnosis: malignant | 6 (42.9) | 9 (64.3) | 0.45 |
| Nonsmall cell lung cancer | 6 | 7 | |
| Small cell lung cancer | 0 | 0 | |
| Lymphoma | 0 | 0 | |
| Metastatic malignancy | 0 | 2 | |
| Final diagnosis: nonmalignant | 8 (57.1) | 5 (35.7) | |
| Sarcoidosis | 1 | 2 | |
| Reactive (adequate sample) | 7 | 3 |
Data are presented as n, mean±sd or n (%), unless otherwise stated. TBLB: transbronchial lung biopsy; EBUS: endobronchial ultrasound; TBNA: transbronchial needle aspiration.
Comfort and sedation scores, bispectral index (BIS) data and further secondary end-points
| 10-point Likert scale (1–10) | 2.2±1.57 | 2.2±1.38 | −0.01 (−0.61–0.63) | 0.97 |
| Willingness to have repeat procedure | 97.7 | 91.8 | 5.9 (−4.8–15.5) | 0.37 |
| 10-point Likert scale (1–10) | 2.6±2.02 | 2.0±1.69 | 0.56 (−0.21–1.34) | 0.16 |
| Perceived willingness to have repeat procedure | 93.9 | 93.2 | −0.7 (−11.8–10.1) | 0.89 |
| 10-point Likert scale (1–10) | 3.7±2.99 | 2.6±2.42 | 1.13 (−0.003–2.25) | 0.05 |
| Perceived willingness to have repeat procedure | 63.3 | 91.0 | −27.6 (−42.4–−10.4) | <0.01 |
| Proceduralist | 2.5±1.53 | 1.1±1.15 | 1.42 (0.86–1.98) | <0.01 |
| Nurse assistant | 2.6±1.74 | 1.1±1.41 | 1.4 (0.76–2.07) | <0.01 |
| 39 (79.6) | 36 (81.8) | |||
| <0.01 | ||||
| <40% | 0±0 | 39.6±30.5 | −39.6 (−49.3–−29.8) | |
| 40–60% | 1.0±4.2 | 20.7±18.8 | −19.7 (−25.9–−13.6) | |
| 60–80% | 9.8±14.3 | 14.5±14.9 | −4.7 (−11.4–2.0) | |
| >80% | 89.2±15.7 | 25.2±28.9 | 64.0 (53.4–74.6) | |
| >90% | 50.9±24.8 | 12.8±19.2 | 38.1 (27.8–48.4) | |
| 33.0±11.8 | 38.2±14.7 | 5.2 (−0.3–10.8) | 0.07 | |
| 4.7±1.0 | 5.9±1.1 | 1.3 (0.8–1.7) | <0.01 | |
| 3 (6.1) | 13 (29.6) | −23.4% (−37.8–−7.4%) | <0.01 | |
| Sedation-related | 0 | 0 | ||
| Anaesthetic-related | 3 (6.1) | 13 (29.6) | −23.4% (−37.8–−7.4%) | <0.01 |
Data are presented as mean±sd, % or n (%), unless otherwise stated. mOAA/S: modified Observers Assessment of Alertness/Sedation scale.
FIGURE 2Matched-pairs analysis of 10-point Likert scale of comfort (higher score indicates more discomfort; each line represents one subject, sorted in ascending subject rating, then nurse/proceduralist rating). a) Subject assessment versus proceduralist's perception; b) subject assessment versus nurse's perception.
FIGURE 3Least-squares (LS) means plot of time at bispectral index (BIS) levels from random-effects repeated-measures analysis.
FIGURE 4Regression analysis of percentage time with bispectral index (BIS) >80 versus proceduralist sedation score (modified Observers Assessment of Alertness/Sedation (mOAA/S) scale).
Diagnostic yield, diagnostic accuracy and procedure-specific data for all diagnostic bronchoscopies, those assessing for a diagnosis of malignancy and endobronchial ultrasound (EBUS) transbronchial needle aspiration (TBNA)
| 47 | 39 | ||
| Procedure not completed | 3 | 1 | 0.62 |
| Diagnostic yield | 34 (72.3) | 34 (87.2) | 0.11 |
| 33 | 37 | ||
| Procedure not completed | 1 | 1 | |
| Lost to follow-up | 1 | 0 | |
| Sensitivity % | 83.3 | 75.0 | |
| NPV % | 91.3 | 77.3 | |
| Diagnostic accuracy % (95% CI) | 93.9 (80.4–98.3) | 86.5 (72.0–94.1) | 0.43 |
| 14 | 14 | ||
| Procedure not completed | 0 | 0 | |
| Lost to follow-up | 0 | 0 | |
| 0.28 | |||
| Paratracheal (2, 4) | 11 (46) | 5 (24) | |
| Subcarinal (7) | 4 (17) | 6 (29) | |
| Hilar (10, 11, 12) | 9 (38) | 10 (48) | |
| Total | 24 | 21 | |
| 3.28±0.8 | 3.00±1.0 | 0.29 | |
| 100 | 87.5 | ||
| 100 | 85.7 | ||
| 100 | 92.9 | 0.39 |
Data are presented as n, n (%) or mean±sd, unless otherwise stated. NPV: negative predictive value.